Diane Stephenson, PhD
Executive Director, CAMD
|
Steve Broadbent, MBA
Chief Operating Officer,
Critical Path Institute
|
Martha A. Brumfield, PhD
President and CEO,
Critical Path Institute |
Klaus Romero MD, MS, FCP
Clinical Pharmacologist and Assistant Program Director,
Critical Path Institute
|
Robin Shane
Project Coordinator, CAMD and
Consortia Operations
|
|
